Study of LP-184 in Patients With Advanced Solid Tumors
Study of LP-184 in Patients With Advanced Solid Tumors
Active, not recruiting · NCT05933265 · Registry updated 2026-05-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of LP-184 in Patients With Advanced Solid Tumors | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, glioblastoma, neoplasm, non-small cell lung carcinoma, pancreatic adenocarcinoma, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-04 | NCT05933265 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lantern Pharma Inc. | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| Highlands Oncology Group | Springdale | United States | 1 |
| Indiana University Melvin and Bren Simon Cancer Center | Indianapolis | United States | 17 |
| John Hopkins - The Sidney Kimmel Comprehensive Cancer Center | Baltimore | United States | 1 |
| Norton Healthcare, Inc. | Louisville | United States | 1 |
| START Mountain Region | West Valley City | United States | 46 |
| UT Health Science Center San Antonio | San Antonio | United States | 2 |